Decision 43/33

The Executive Committee decided to approve the project for the phase-out of CFC consumption in the manufacture of metered-dose inhalers in Uruguay at a total cost of US $427,023 plus agency support costs of US $32,027 for UNDP, noting that the firm assumed the risk of conversion to new formulations and that Government of Uruguay had agreed that no additional resources would be requested from the Multilateral Fund for activities related to the phase-out of CFCs used for the manufacturing of metered-dose inhalers.